23andMe

Sandy on December 18th, 2013

I’d like to share the following article published in USA Today with a focus on blocking 23andMe from spreading awareness of the benefits of genetic testing. It’s suggested that the FDA is worried that by giving Americans more access to more information regarding their genomes they might get too much medical care. See below: “The […]

Continue reading about FDA oversteps on genetic testing: Opposing view

The following Warning Letter dated November 22, 2013, was sent to Ann Wojcicki, CEO of 23andMe, Inc., regarding the marking of the 23andMe Saliva Collection Kit and Personal Genome Service without marketing clearance and approval in violation of the Federal Food, Drug and Cosmetic Act. I’ve left off the address, which you can find on […]

Continue reading about 23andMe gets Warning Letter from U.S. Food and Drug Administration (FDA)

Some of you may have read in newspaper or heard on TV that the journal Science stated that they had discovered that a genetic signature could predict longevity. I’d like to share a blog post by 23andMe informing readers that the authors have formally retracted the longevity study as follows: “Last summer, a study published in the […]

Continue reading about Controversial DNA longevity paper formally retracted